Pharmalucence formally CIS-US Inc.
Careers News Resources Contact  
  Manufacturing Capabilities
  Facility Details 
  Nuclear Medicine Products

Company News
Come See Us
Company News

December 09, 2013

Pharmalucence announces manufacturing contract at its new parenteral manufacturing facility in Billerica, MA

BILLERICA, Mass. (December 9, 2013) – Pharmalucence, Inc. ( today announced that it has entered into an agreement with Lantheus Medical Imaging, Inc. ( to serve as a contract manufacturer of DEFINITY®  Vial for (Perflutren Lipid Microsphere) Injectable Suspension for contrast-enhanced echocardiography. The contract secures manufacturing capacity for Lantheus at the newly constructed Pharmalucence drug production facility in Billerica, MA for a minimum of 10 years. 

Ed Connolly, Pharmalucence Chief Operating Officer, stated, “Pharmalucence has established a world-class manufacturing facility here in New England, which has been recognized by companies who choose to outsource their manufacturing. We are extremely pleased to partner with Lantheus, a local company with a reputation for exceptional product innovation and quality, for the supply of DEFINITY®.” 

“Our manufacturing agreement with Pharmalucence is a vital component of our plan to secure long-term supply of DEFINITY®,” said Jeff Bailey, Lantheus President and Chief Executive Officer. “We look forward to working with Pharmalucence, who has a shared commitment to deliver the highest quality products to the customers and patients who benefit from DEFINITY®.”
About Pharmalucence, Inc.
Pharmalucence,, is a leading provider of Technetium Tc 99m radiopharmaceuticals and contract manufacturer specializing in fill and finish of liquid and lyophilized human injectables. Its new 70,000 sq. ft. manufacturing facility features fully automated, isolated aseptic filling technology for markets worldwide. Founded in 2007, Pharmalucence is a privately-held, U.S. based, employee-owned company. 
About Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, is dedicated to creating and providing pioneering medical imaging solutions to improve the treatment of human disease. The Company’s proven success in the field of diagnostic imaging provides a strong platform from which to bring forward breakthrough tools for the diagnosis and management of disease. Lantheus has approximately 550 employees worldwide with headquarters in North Billerica, Massachusetts, and offices in Puerto Rico, Canada and Australia. For more information, visit

For more information, please contact:
John Felock
Director; Sales, Marketing and Customer Service

29 Dunham Road, Billerica, MA 01821 | Telephone: 781-275-7120    © Pharmalucence Inc. All rights reserved.